- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 88.56M sh |
| Long Term Debt | Q1 2025 · Mar 30, 2025 | $822.54M |
| Long Term Debt | Q1 2025 · Dec 29, 2024 | $843.86M |
| Short Term Debt | Q1 2025 · Mar 30, 2025 | $28.93M |
| Short Term Debt | Q1 2025 · Dec 29, 2024 | $30.02M |
| Current Liabilities | Q1 2025 · Mar 30, 2025 | $340.48M |
| Current Liabilities | Q1 2025 · Dec 29, 2024 | $382.33M |
| Total Liabilities | Q1 2025 · Mar 30, 2025 | $1.45B |
| Total Liabilities | Q1 2025 · Dec 29, 2024 | $1.51B |
| Current Assets | Q1 2025 · Mar 30, 2025 | $536.08M |
| Current Assets | Q1 2025 · Dec 29, 2024 | $601.38M |
| Total Assets | Q1 2025 · Mar 30, 2025 | $1.99B |
| Total Assets | Q1 2025 · Dec 29, 2024 | $2.07B |
| Cash And Equivalents | Q1 2025 · Dec 29, 2024 | $49.02M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 71.67M sh |
| Capex restated | Q1 2025 · Mar 31, 2024 | $26.26M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$26.45M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $197.77M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $225.99M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.35 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.35 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $28.55M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$25.06M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$21.94M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $13.28M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $514.74M |
| Revenue | Q1 2025 · Mar 31, 2024 | $528.02M |